Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 2 Study combining BGB-3111 with Obinutuzumab compared with Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma Ended

2023-509975-17-00 Relapsed/Refractory Follicular Lymphoma 4 2018-04-12
Intermittent ibrutinib in chronic lymphocytic leukemia Ended

2023-508638-32-00 Chronic lymphocytic leukemia 3 2018-04-06
A Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemothe… Ended

2023-504209-35-00 Early-Stage Resectable Non-small cell lung cancer (NSCL 5 2018-04-04
A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (… Ended

2024-516904-40-00 Previously Untreated Diffuse large B-cell lymphoma (DLB 5 2018-03-27
A Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Urothelial Cancer Ended

2023-510296-56-00 Advanced Urothelial Cancer 5 2018-03-26
Safety and pharmacokinetics of odm-208 in patients with metastatic castration-resistant prostate cancer Ended

2024-517439-39-00 Metastatic castration-resistant prostate cancer. 7 2018-03-19
A study to assess the safety and anti-tumor activity of T cell therapy in subjects with advanced liver cancer or any other AFP expressing tu… Ended

2024-514437-37-00 Advanced Hepatocellular Carcinoma (HCC) that is not ame 1 2018-02-22
A study to find out if an investigational product, called LN-145 (also called tumor infiltrating lymphocytes) is an effective and safe treat… Ended

2024-510634-41-00 Recurrent, metastatic, or persistent Cervical Carcinoma 4 2018-02-22
KRd consolidation in myeloma patients with a positive PET-CT after standard first line treatment. A phase II study Ended

2024-511714-20-00 Multiple Myeloma 4 2018-01-30
A Phase 3 randomized clinical Study of Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line trea… Ended

2024-512015-47-00 Histologically or cytologically-confirmed Recurrent or 5 2018-01-09
Pembrolizumab (MK-3475) plus Epacadostat vs SoC in mRCC Ended

2024-512016-22-00 Locally advanced/metastatic renal cell carcinoma 5 2017-12-27
Safety and efficacy of IMCgp100 versus Investigator’s Choice in advanced uveal melanoma Ended

2024-517290-24-00 Previously untreated advanced uveal melanoma (UM) 4 2017-12-19
Study of the safety, activity, and effect on the body of ASTX660 in people with advanced cancers. Ended

2024-516679-33-00 Advanced Solid Tumors and Lymphomas that are metastatic 7 2017-12-01
Phase 3 Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Canc… Ended

2024-513167-68-00 endometrial cancer 5 2017-11-29
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Pancreatic Duc… Ended

2024-511271-15-00 Pancreatic ductal adenocarcinoma (PDAC) 9 2017-11-23
A clinical study to compare the safety, effectiveness and pharmacokinetics (the way the body absorbs, distributes, and gets rid of a drug) o… Ended

2023-507143-11-00 Precancerous form of blood cancer in the bone marrow 5 2017-11-08
Perioperative treatment of locally advanced resectable gastric or GEJ adenocarcinoma Ended

2023-509595-42-00 Gastric and gastroesophageal junction (GEJ) adenocarcin 5 2017-10-31
A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Cabozantinib versus Sunitinib in Participants with Previously Untreated, … Ended

2023-509711-83-00 Advanced or Metastatic Renal Cell Carcinoma 5 2017-10-27
A Study of Venetoclax Co-Administered with Low Dose Cytarabine Versus Low Dose Cytarabine in Untreated Patients with Acute Myeloid Leukemia … Ended

2024-513630-37-00 Acute Myeloid Leukemia 5 2017-10-24
First-line immunotherapy using Wilms’ tumor protein 1 (WT1)-targeted dendritic cell vaccinations for malignant pleural mesothelioma Ended

2024-517970-35-00 Malignant Pleural Mesothelioma 4 2017-10-03
Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3C… Ended

2023-509167-24-00 Adult patients with PIK3CA mutant, HR-positive, HER2-ne 4 2017-10-02
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) Ended

2024-515052-20-00 Non-small Cell Lung Cancer 5 2017-09-20
A Study of Nivolumab and Ipilimumab Combined with Chemotherapy Compared to Chemotherapy by Itself as the First Treatment Given for Stage IV … Ended

2023-508757-75-00 Stage IV Non-Small Cell Lung Cancer (NSCLC) 5 2017-09-18
Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM14 Administered Intravenously to Patients with Advanced Solid … Ended

2024-511916-25-00 Advanced Solid Tumors 7 2017-09-04